HEADER HYDROLASE/HYDROLASE INHIBITOR 31-OCT-07 3B7V
TITLE HIV-1 PROTEASE COMPLEXED WITH GEM-DIOL-AMINE TETRAHEDRAL INTERMEDIATE
TITLE 2 NLLTQI
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: PROTEASE;
COMPND 3 CHAIN: A, B;
COMPND 4 FRAGMENT: UNP RESIDUES 501-599;
COMPND 5 SYNONYM: RETROPEPSIN;
COMPND 6 EC: 3.4.23.16;
COMPND 7 ENGINEERED: YES;
COMPND 8 MUTATION: YES;
COMPND 9 MOL_ID: 2;
COMPND 10 MOLECULE: PEPTIDE;
COMPND 11 CHAIN: C;
COMPND 12 FRAGMENT: SELF PROTEOLYTIC PRODUCT OF HIV-1 PROTEASE;
COMPND 13 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 BH10;
SOURCE 3 ORGANISM_TAXID: 11678;
SOURCE 4 STRAIN: BH5 ISOLATE;
SOURCE 5 GENE: GAG-POL;
SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3);
SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008;
SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3);
SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID;
SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET11A;
SOURCE 11 MOL_ID: 2;
SOURCE 12 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 BH10;
SOURCE 13 ORGANISM_TAXID: 11678;
SOURCE 14 STRAIN: BH5 ISOLATE;
SOURCE 15 GENE: GAG-POL;
SOURCE 16 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3);
SOURCE 17 EXPRESSION_SYSTEM_TAXID: 469008;
SOURCE 18 EXPRESSION_SYSTEM_STRAIN: BL21(DE3);
SOURCE 19 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID;
SOURCE 20 EXPRESSION_SYSTEM_PLASMID: PET11A
KEYWDS HYDROLASE-HYDROLASE INHIBITOR COMPLEX
EXPDTA X-RAY DIFFRACTION
AUTHOR A.Y.KOVALEVSKY,A.A.CHUMANEVICH,I.T.WEBER
REVDAT 7 30-AUG-23 3B7V 1 REMARK
REVDAT 6 20-OCT-21 3B7V 1 REMARK SEQADV LINK
REVDAT 5 25-OCT-17 3B7V 1 REMARK
REVDAT 4 13-JUL-11 3B7V 1 VERSN
REVDAT 3 24-FEB-09 3B7V 1 VERSN
REVDAT 2 25-DEC-07 3B7V 1 JRNL
REVDAT 1 18-DEC-07 3B7V 0
JRNL AUTH A.Y.KOVALEVSKY,A.A.CHUMANEVICH,F.LIU,J.M.LOUIS,I.T.WEBER
JRNL TITL CAUGHT IN THE ACT: THE 1.5 A RESOLUTION CRYSTAL STRUCTURES
JRNL TITL 2 OF THE HIV-1 PROTEASE AND THE I54V MUTANT REVEAL A
JRNL TITL 3 TETRAHEDRAL REACTION INTERMEDIATE.
JRNL REF BIOCHEMISTRY V. 46 14854 2007
JRNL REFN ISSN 0006-2960
JRNL PMID 18052235
JRNL DOI 10.1021/BI700822G
REMARK 2
REMARK 2 RESOLUTION. 1.46 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : SHELXL-97
REMARK 3 AUTHORS : G.M.SHELDRICK
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.46
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 10.00
REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000
REMARK 3 COMPLETENESS FOR RANGE (%) : 97.6
REMARK 3 CROSS-VALIDATION METHOD : FREE R
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF).
REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.155
REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.152
REMARK 3 FREE R VALUE (NO CUTOFF) : 0.212
REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 5.000
REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 2006
REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 40494
REMARK 3
REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F).
REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : 0.138
REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : 0.135
REMARK 3 FREE R VALUE (F>4SIG(F)) : 0.196
REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : 5.000
REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : 1654
REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : 32850
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 1562
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 10
REMARK 3 SOLVENT ATOMS : 172
REMARK 3
REMARK 3 MODEL REFINEMENT.
REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : 1715.2
REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : 1618.0
REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : 18
REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : 16443
REMARK 3 NUMBER OF RESTRAINTS : 20980
REMARK 3
REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES.
REMARK 3 BOND LENGTHS (A) : 0.011
REMARK 3 ANGLE DISTANCES (A) : 0.030
REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : 0.000
REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : 0.027
REMARK 3 ZERO CHIRAL VOLUMES (A**3) : 0.001
REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : 0.001
REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : 0.013
REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : 0.009
REMARK 3 SIMILAR ADP COMPONENTS (A**2) : 0.063
REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : 0.083
REMARK 3
REMARK 3 BULK SOLVENT MODELING.
REMARK 3 METHOD USED: NULL
REMARK 3
REMARK 3 STEREOCHEMISTRY TARGET VALUES : ENGH AND HUBER
REMARK 3 SPECIAL CASE: NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: ANISOTROPIC REFINEMENT REDUCED FREE R
REMARK 3 (NO CUTOFF)
REMARK 4
REMARK 4 3B7V COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 15-NOV-07.
REMARK 100 THE DEPOSITION ID IS D_1000045188.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : NULL
REMARK 200 TEMPERATURE (KELVIN) : 100
REMARK 200 PH : 6.0
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : APS
REMARK 200 BEAMLINE : 22-ID
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 1.0
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : CCD
REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 300 MM CCD
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MAR
REMARK 200 DATA SCALING SOFTWARE : SCALEPACK
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 32850
REMARK 200 RESOLUTION RANGE HIGH (A) : 1.460
REMARK 200 RESOLUTION RANGE LOW (A) : 50.000
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : NULL
REMARK 200 DATA REDUNDANCY : NULL
REMARK 200 R MERGE (I) : 0.10300
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL
REMARK 200 COMPLETENESS FOR SHELL (%) : NULL
REMARK 200 DATA REDUNDANCY IN SHELL : NULL
REMARK 200 R MERGE FOR SHELL (I) : NULL
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: AB INITIO
REMARK 200 SOFTWARE USED: SHELX
REMARK 200 STARTING MODEL: PDB ENTRY 2IEN
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 53.56
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.62
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 50MM SODIUM PHOSPHATE/100MM SODIUM
REMARK 280 CITRATE, 10% NACL (W/W), 2.5% GLYCEROL (V/V), PH 6.0, VAPOR
REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 298K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X,-Y,Z
REMARK 290 3555 -X+1/2,Y+1/2,-Z
REMARK 290 4555 X+1/2,-Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 29.15200
REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 43.06050
REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000
REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 29.15200
REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 43.06050
REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 300 REMARK: THE AUTHORS STATE THAT THE BIOLOGICAL ASSEMBLY
REMARK 300 IS COMPOSED OF THE HIV-1 PROTEASE DIMER,
REMARK 300 COMPLEXED WITH ITS SUBSTRATE, THE GEM-DIOL-AMINE
REMARK 300 TETRAHEDRAL INTERMEDIATE PEPTIDE NLLTQI
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 TOTAL BURIED SURFACE AREA: 5890 ANGSTROM**2
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 400
REMARK 400 COMPOUND
REMARK 400
REMARK 400 THE N-{(2S)-2-[(L-ASPARAGINYL-L-LEUCYL)AMINO]-1,1-DIHYDROXY-4-
REMARK 400 METHYLPENTYL}-L-THREONYL-L-GLUTAMINYL-L-ISOLEUCINE IS PEPTIDE-LIKE,
REMARK 400 A MEMBER OF INHIBITOR CLASS.
REMARK 400
REMARK 400 GROUP: 1
REMARK 400 NAME: N-{(2S)-2-[(L-ASPARAGINYL-L-LEUCYL)AMINO]-1,1-DIHYDROXY-4-
REMARK 400 METHYLPENTYL}-L-THREONYL-L-GLUTAMINYL-L-ISOLEUCINE
REMARK 400 CHAIN: C
REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER
REMARK 400 DESCRIPTION: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: COVALENT BOND ANGLES
REMARK 500
REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES
REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE
REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1)
REMARK 500
REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999
REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996
REMARK 500
REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3
REMARK 500 ARG A 41 NE - CZ - NH1 ANGL. DEV. = -4.7 DEGREES
REMARK 500 ARG A 41 NE - CZ - NH2 ANGL. DEV. = 3.6 DEGREES
REMARK 500 ARG A 87 NE - CZ - NH1 ANGL. DEV. = 4.2 DEGREES
REMARK 500 ARG A 87 NE - CZ - NH2 ANGL. DEV. = -3.1 DEGREES
REMARK 500 ARG B 141 NE - CZ - NH2 ANGL. DEV. = -3.8 DEGREES
REMARK 500 ARG B 187 NE - CZ - NH1 ANGL. DEV. = 4.2 DEGREES
REMARK 500 LNT C 203 CA - C - N ANGL. DEV. = 20.2 DEGREES
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS
REMARK 500
REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH
REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED
REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND
REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES.
REMARK 500 MODEL OMEGA
REMARK 500 LNT C 203 GLN C 205 -112.91
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY
REMARK 500
REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY
REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER
REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME;
REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER;
REMARK 500 I=INSERTION CODE).
REMARK 500
REMARK 500 M RES CSSEQI ANGLE
REMARK 500 LNT C 203 40.36
REMARK 500
REMARK 500 REMARK: NULL
REMARK 620
REMARK 620 METAL COORDINATION
REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE):
REMARK 620
REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL
REMARK 620 NA A 901 NA
REMARK 620 N RES CSSEQI ATOM
REMARK 620 1 ASP A 60 O
REMARK 620 2 HOH A1010 O 104.3
REMARK 620 3 HOH A1023 O 94.0 72.6
REMARK 620 4 HOH A1123 O 98.8 147.7 83.7
REMARK 620 5 HOH A1124 O 169.3 85.8 85.8 70.5
REMARK 620 6 HOH A1125 O 79.4 105.1 172.4 101.0 101.4
REMARK 620 N 1 2 3 4 5
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NA A 901
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 902
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC3
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL B 903
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC4
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL B 904
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC5
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL B 905
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC6
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN C OF PEPTIDE
REMARK 900
REMARK 900 RELATED ENTRIES
REMARK 900 RELATED ID: 3B80 RELATED DB: PDB
REMARK 900 HIV-1 PROTEASE MUTANT I54V COMPLEXED WITH GEM-DIOL-AMINE
REMARK 900 INTERMEDIATE NLLTQI
DBREF 3B7V A 1 99 UNP P04587 POL_HV1B5 501 599
DBREF 3B7V B 101 199 UNP P04587 POL_HV1B5 501 599
DBREF 3B7V C 201 206 PDB 3B7V 3B7V 201 206
SEQADV 3B7V LYS A 7 UNP P04587 GLN 507 ENGINEERED MUTATION
SEQADV 3B7V ILE A 33 UNP P04587 LEU 533 ENGINEERED MUTATION
SEQADV 3B7V ILE A 63 UNP P04587 LEU 563 ENGINEERED MUTATION
SEQADV 3B7V ALA A 67 UNP P04587 CYS 567 ENGINEERED MUTATION
SEQADV 3B7V ALA A 95 UNP P04587 CYS 595 ENGINEERED MUTATION
SEQADV 3B7V LYS B 107 UNP P04587 GLN 507 ENGINEERED MUTATION
SEQADV 3B7V ILE B 133 UNP P04587 LEU 533 ENGINEERED MUTATION
SEQADV 3B7V ILE B 163 UNP P04587 LEU 563 ENGINEERED MUTATION
SEQADV 3B7V ALA B 167 UNP P04587 CYS 567 ENGINEERED MUTATION
SEQADV 3B7V ALA B 195 UNP P04587 CYS 595 ENGINEERED MUTATION
SEQRES 1 A 99 PRO GLN ILE THR LEU TRP LYS ARG PRO LEU VAL THR ILE
SEQRES 2 A 99 LYS ILE GLY GLY GLN LEU LYS GLU ALA LEU LEU ASP THR
SEQRES 3 A 99 GLY ALA ASP ASP THR VAL ILE GLU GLU MET SER LEU PRO
SEQRES 4 A 99 GLY ARG TRP LYS PRO LYS MET ILE GLY GLY ILE GLY GLY
SEQRES 5 A 99 PHE ILE LYS VAL ARG GLN TYR ASP GLN ILE ILE ILE GLU
SEQRES 6 A 99 ILE ALA GLY HIS LYS ALA ILE GLY THR VAL LEU VAL GLY
SEQRES 7 A 99 PRO THR PRO VAL ASN ILE ILE GLY ARG ASN LEU LEU THR
SEQRES 8 A 99 GLN ILE GLY ALA THR LEU ASN PHE
SEQRES 1 B 99 PRO GLN ILE THR LEU TRP LYS ARG PRO LEU VAL THR ILE
SEQRES 2 B 99 LYS ILE GLY GLY GLN LEU LYS GLU ALA LEU LEU ASP THR
SEQRES 3 B 99 GLY ALA ASP ASP THR VAL ILE GLU GLU MET SER LEU PRO
SEQRES 4 B 99 GLY ARG TRP LYS PRO LYS MET ILE GLY GLY ILE GLY GLY
SEQRES 5 B 99 PHE ILE LYS VAL ARG GLN TYR ASP GLN ILE ILE ILE GLU
SEQRES 6 B 99 ILE ALA GLY HIS LYS ALA ILE GLY THR VAL LEU VAL GLY
SEQRES 7 B 99 PRO THR PRO VAL ASN ILE ILE GLY ARG ASN LEU LEU THR
SEQRES 8 B 99 GLN ILE GLY ALA THR LEU ASN PHE
SEQRES 1 C 5 ASN LEU LNT GLN ILE
HET LNT C 203 16
HET NA A 901 1
HET CL A 902 1
HET CL B 903 1
HET CL B 904 1
HET GOL B 905 6
HETNAM LNT N-[(2S)-2-AMINO-1,1-DIHYDROXY-4-METHYLPENTYL]-L-
HETNAM 2 LNT THREONINE
HETNAM NA SODIUM ION
HETNAM CL CHLORIDE ION
HETNAM GOL GLYCEROL
HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL
FORMUL 3 LNT C10 H22 N2 O5
FORMUL 4 NA NA 1+
FORMUL 5 CL 3(CL 1-)
FORMUL 8 GOL C3 H8 O3
FORMUL 9 HOH *172(H2 O)
HELIX 1 1 GLY A 86 THR A 91 1 6
HELIX 2 2 GLN A 92 GLY A 94 5 3
HELIX 3 3 GLY B 186 THR B 191 1 6
SHEET 1 A 4 GLN A 2 ILE A 3 0
SHEET 2 A 4 THR B 196 ASN B 198 -1 O LEU B 197 N ILE A 3
SHEET 3 A 4 THR A 96 ASN A 98 -1 N THR A 96 O ASN B 198
SHEET 4 A 4 GLN B 102 ILE B 103 -1 O ILE B 103 N LEU A 97
SHEET 1 B 8 TRP A 42 GLY A 49 0
SHEET 2 B 8 GLY A 52 ILE A 66 -1 O VAL A 56 N LYS A 45
SHEET 3 B 8 HIS A 69 VAL A 77 -1 O HIS A 69 N ILE A 66
SHEET 4 B 8 VAL A 32 ILE A 33 1 N ILE A 33 O LEU A 76
SHEET 5 B 8 ILE A 84 ILE A 85 -1 O ILE A 84 N VAL A 32
SHEET 6 B 8 GLN A 18 LEU A 24 1 N LEU A 23 O ILE A 85
SHEET 7 B 8 LEU A 10 ILE A 15 -1 N ILE A 13 O LYS A 20
SHEET 8 B 8 GLY A 52 ILE A 66 -1 O GLU A 65 N LYS A 14
SHEET 1 C 8 LYS B 143 GLY B 149 0
SHEET 2 C 8 GLY B 152 ILE B 166 -1 O GLN B 158 N LYS B 143
SHEET 3 C 8 HIS B 169 VAL B 177 -1 O HIS B 169 N ILE B 166
SHEET 4 C 8 VAL B 132 ILE B 133 1 N ILE B 133 O LEU B 176
SHEET 5 C 8 ILE B 184 ILE B 185 -1 O ILE B 184 N VAL B 132
SHEET 6 C 8 GLN B 118 LEU B 124 1 N LEU B 123 O ILE B 185
SHEET 7 C 8 LEU B 110 ILE B 115 -1 N ILE B 113 O LYS B 120
SHEET 8 C 8 GLY B 152 ILE B 166 -1 O GLU B 165 N LYS B 114
LINK C LEU C 202 N14 LNT C 203 1555 1555 1.37
LINK O ASP A 60 NA NA A 901 1555 1555 2.30
LINK NA NA A 901 O HOH A1010 1555 1555 2.31
LINK NA NA A 901 O HOH A1023 1555 1555 2.54
LINK NA NA A 901 O HOH A1123 1555 1555 2.41
LINK NA NA A 901 O HOH A1124 1555 1555 2.97
LINK NA NA A 901 O HOH A1125 1555 1555 2.29
SITE 1 AC1 6 ASP A 60 HOH A1010 HOH A1023 HOH A1123
SITE 2 AC1 6 HOH A1124 HOH A1125
SITE 1 AC2 3 THR A 74 ASN A 88 ARG B 141
SITE 1 AC3 1 TRP B 106
SITE 1 AC4 3 THR B 174 ASN B 188 HOH B1060
SITE 1 AC5 6 GLY A 16 GLN A 18 PRO B 101 ALA B 167
SITE 2 AC5 6 HIS B 169 HOH B1094
SITE 1 AC6 32 ARG A 8 ASP A 25 GLY A 27 ALA A 28
SITE 2 AC6 32 ASP A 29 ASP A 30 VAL A 32 ILE A 47
SITE 3 AC6 32 GLY A 48 GLY A 49 ILE A 50 VAL A 82
SITE 4 AC6 32 ILE A 84 HOH A1001 HOH A1036 ARG B 108
SITE 5 AC6 32 LEU B 123 ASP B 125 GLY B 127 ALA B 128
SITE 6 AC6 32 ASP B 129 ASP B 130 ILE B 147 GLY B 148
SITE 7 AC6 32 GLY B 149 ILE B 150 PHE B 153 PRO B 181
SITE 8 AC6 32 VAL B 182 ILE B 184 HOH C1051 HOH C1101
CRYST1 58.304 86.121 46.307 90.00 90.00 90.00 P 21 21 2 8
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.017151 0.000000 0.000000 0.00000
SCALE2 0.000000 0.011612 0.000000 0.00000
SCALE3 0.000000 0.000000 0.021595 0.00000